News | February 14, 2023
NATCO files generic Olaparib Tablets in USA
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
A pharma industry veteran with over three decades of experience in domestic as well as international markets
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
He is a Chartered Accountant with more than 19 years of extensive experience
The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities
Subscribe To Our Newsletter & Stay Updated
